Mydecine Innovations Group

Mydecine Innovations Group Mydecine subsidiary, Mindleap Health, as also built out a world-class mental health app for personal therapy and for clinical trial use (Mindleap.com).

Mydecine (NEO:MYCO) (OTC:MYCOF) has built out facilities in Denver and Canada that are dedicated to developing innovative solutions from fungal sources for treating mental health disorders and enhancing vitality with psychedelic and functional mushrooms. Mydecine Innovations Group™ (NEO: MYCO) (OTC:MYCOF) is a life sciences company dedicated to developing and commercializing innovative solutions f

or treating mental health problems and enhancing wellbeing. The company’s world-renowned scientists are building out a robust R&D pipeline and developing a strong IP portfolio of nature-sourced psychedelic therapeutics, novel compounds, and unique delivery systems. Mydecine has a fully certified CGMP pharmaceutical facility with the ability to research psychedelic compounds with full government approval through Health Canada. Mydecine also operates out of a state-of-the-art mycology lab in Denver, CO to focus on genetic and pharmacology research on (non-psychedelic) medicinal mushrooms.

Mydecine COO Damon Michaels is back on The Dales Report!In this episode, Michaels shares our exciting five-year partners...
09/01/2021

Mydecine COO Damon Michaels is back on The Dales Report!

In this episode, Michaels shares our exciting five-year partnership with Johns Hopkins University, reflects on how fast the industry has progressed in the last 12 months, our advancements with our lead drug candidates MYCO-001 AND MYCO-004, and our goals to expand the treatment options for those that need it.

In our first interview with Mydecine Innovations Group (NEO: MYCO)(OTCMKTS: MYCOF) we talked about the five-year agreement with the Johns Hopkins University ...

Mydecine CEO Josh Bartch discusses our Q2 2021 performance, and told investors the company made “groundbreaking progress...
08/25/2021

Mydecine CEO Josh Bartch discusses our Q2 2021 performance, and told investors the company made “groundbreaking progress” and discoveries in its compound research and program.

Explore the link below to learn about our therapeutics and more exciting updates.

CEO Joshua Bartach told investors the company made “groundbreaking progress” and discoveries in its psilocybin compound research and drug development program.

08/23/2021

Did you know there are over 100 different types of soil in Jamaica?

Mydecine COO, Damon Michaels sits down with The Dales Report to discuss the benefits of having Jamaica as a base for our mushroom cultivation, not only in terms of legality but in the fertility of Jamaican soil which contributes to the variety of genetic species.

We are excited to announce that we have signed a five-year research agreement with The Johns Hopkins University School o...
08/19/2021

We are excited to announce that we have signed a five-year research agreement with The Johns Hopkins University School of Medicine! Our research will be led by Dr. Matthew W. Johnson, Ph.D., and professor of Psychiatry and Behavioral Sciences.

Click here for the full press release 👉 fal.cn/3hyEa

We are proud to sponsor the 2021 Telluride Mushroom Festival, a community gathering to celebrate all things fungi. Come ...
08/16/2021

We are proud to sponsor the 2021 Telluride Mushroom Festival, a community gathering to celebrate all things fungi. Come say hi at the Mydecine tent from August 18th thru 22nd to meet our team of Mycologists and to learn about the latest advancements in , chemistry, clinical use of and medicinal mushrooms - AND MORE!

See you there! 🍄

The Telluride Mushroom Festival celebrates all things mycological, from the newest advancements in mushroom science to our famous mushroom cook-off. Annually...

The 5-day countdown begins for the Telluride Mushroom Festival, an event proudly sponsored in part by Mydecine. We can’t...
08/13/2021

The 5-day countdown begins for the Telluride Mushroom Festival, an event proudly sponsored in part by Mydecine. We can’t wait to hear Paul Stamets’ review of the history of mushrooms, and explore the current breakthrough discoveries on the benefits of mushrooms as sources of medicines for therapeutic and physiological benefits.

Join us from August 18th thru 22nd to celebrate all things fungi! Be sure to stop by and say hi at the Mydecine tent to meet our team of mycologists, play trivia, win a raffle, listen to live performances… AND MORE!

It is suggested that   may temporarily dissolve the ego, allowing individuals to experience changes in consciousness.Myd...
08/12/2021

It is suggested that may temporarily dissolve the ego, allowing individuals to experience changes in consciousness.

Mydecine CMO Dr. Rakesh Jetly shares insights with Leafly
about “ego death” sparked by the psychedelic journey.

Psychedelics can help one experience ego death, or the loss of the self, to gain a connectedness with the world. Learn how ego death can be beneficial to mental health.

We are excited to announce that we have commissioned a local Denver female artist to join us at the Telluride Mushroom F...
08/11/2021

We are excited to announce that we have commissioned a local Denver female artist to join us at the Telluride Mushroom Festival next week to capture this event. will be live painting at the Mydecine tent, and participants will have the opportunity to enter our raffle for a chance to win this original piece of artwork!

Mydecine is the main presenting sponsor of the 2021 Telluride Mushroom Festival, August 18th thru 22nd, a community gathering to celebrate all things fungi. Attendees will hear from experts on the latest advancements in mycology, chemistry and clinical use of psychedelic mushrooms. Be sure to stay tuned for further details on special guest performances and more! 🍄

👉 www.tellurideinstitute.org/telluride-mushroom-festival/

Join us today at 3PM EDT for BTIG’s    , featuring the “Reemergence and Development of Psychedelics in Mental Health Con...
08/10/2021

Join us today at 3PM EDT for BTIG’s , featuring the “Reemergence and Development of Psychedelics in Mental Health Conditions” with hosts Josh Bartch and Rob Roscow.

Learn more here 👉https://fal.cn/3hjFK

We look forward to seeing you online soon!

Leave a comment 🙋‍♀️ below if we will see you at the Telluride Mushroom Festival next week! We are proud to sponsor the ...
08/10/2021

Leave a comment 🙋‍♀️ below if we will see you at the Telluride Mushroom Festival next week!

We are proud to sponsor the 2021 Telluride Mushroom Festival, a community gathering to celebrate all things fungi. Attendees will hear from experts on the latest advancements in , and clinical use of mushrooms, and much more! Stop by the Mydecine tent from August 18th thru 22nd to meet our team of Mycologists, and to learn more about psychedelic and medicinal mushrooms.

Stay tuned for more details on our raffle, special guest performances and more!

👉www.tellurideinstitute.org/telluride-mushroom-festival/

It’s almost time for BTIG’s Biotechnology Conference! We’re excited to announce that Mydecine CEO Josh Bartch and CSO Ro...
08/09/2021

It’s almost time for BTIG’s Biotechnology Conference! We’re excited to announce that Mydecine CEO Josh Bartch and CSO Robert Roscow be hosting a fireside chat will speak tomorrow, August 10th at 3PM EDT. Don’t forget to partake.

DENVER, July 28, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging...

Address

Denver, CO

Alerts

Be the first to know and let us send you an email when Mydecine Innovations Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Mydecine Innovations Group:

Share